Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Charlene Mantia, M.D.

Co-Author

This page shows the publications co-authored by Charlene Mantia and Guru Sonpavde.
Connection Strength

1.661
  1. Editorial Comment. J Urol. 2021 08; 206(2):250-251.
    View in: PubMed
    Score: 0.935
  2. Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma. Oncologist. 2022 Mar 16.
    View in: PubMed
    Score: 0.248
  3. FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma. BJUI Compass. 2022 Mar; 3(2):169-172.
    View in: PubMed
    Score: 0.242
  4. An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer. Urol Oncol. 2021 12; 39(12):834.e1-834.e7.
    View in: PubMed
    Score: 0.236
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.